BeiGene has officially launched its PD-1 cancer drug Tevimbra in the U.S. more than six months after receiving a much-delayed ...

The days of broad stomach cancer labels for PD-1 inhibitors appear to be numbered.  | The days of broad stomach cancer labels ...

Immune checkpoint inhibitors against the PD-1/PD-L1 interaction as therapeutics for various cancers have achieved great success. However, about 70% of patients do not respond well when receiving ...

The Oncologic Drugs Advisory Committee (ODAC) decided 10-2 with one abstention that PD-1 inhibitors do not have a favorable ...

The FDA's advisory committee is set to evaluate the use of PD-1 inhibitors in gastric cancer patients, focusing on the risks ...

The FDA is reassessing the approval of immune checkpoint inhibitors for treating advanced HER2-negative gastric adenocarcinoma, questioning their broad application regardless of patients' PD-L1 ...

The first patient has been treated in a phase 1/2 clinical trial of an experimental Moderna vaccine designed to generate antibodies against PD-L1 and IDO1 – two targets thought to protect ...

Casitas B-lineage lymphoma b (Cbl/b) is an E3 ubiquitin ligase that has been shown to be a key regulator of the activation of T and natural killer (NK) cells in the absence of CD28 costimulation GRC ...

Ivonescimab (AK112) is a novel, potentially first-in-class investigational bi-specific antibody that targets programmed death 1 (PD-1) and vascular endothelial growth factor (VEGF) developed by ...

PD chargers will be rated at either PD 3.0 or PD 3.1. PD 3.0 can charge at up to 100W depending on the maximum output of the charging port; PD 3.1 at up to 240W, although few current laptops ...

DENVER (KDVR) – One person was hurt after trying to recover their stolen vehicle from a suspect early Saturday night, according to the Denver Police Department. A suspect was later arrested ...